Funding for cancer research by an Indian funding agency, DBT

被引:0
|
作者
Sandhya R Shenoy
Bindu Dey
机构
[1] Ministry of Science and Technology,Medical Biotechnology Group, Department of Biotechnology
[2] Former Adviser,undefined
[3] Department of Biotechnology,undefined
[4] Ministry of Science &Technology,undefined
来源
Journal of Biosciences | 2021年 / 46卷
关键词
Cancer research; funding agency;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer is a group of diseases with major societal impact and accounts for approximately 55% of mortality in India. The Indian population is increasing in size and gradually ageing. As a result, the number of people diagnosed with and dying of cancer are increasing. Government funding agencies such as the Department of Biotechnology (DBT) has a clear definitive role in the management and control of cancer. Through Research & Development programs and multi-institutional networking programs, DBT has provided resources to individual investigators and to institutions, to carry out basic, applied, translational and clinical research and to develop new methods to prevent and treat disease and to conduct research especially in challenging areas pertaining to different types of cancer. This article summarizes the funding provided by DBT for different cancer research programs.
引用
收藏
相关论文
共 50 条